Tearsheet

Pennant (PNTG)


Market Price (2/28/2026): $33.71 | Market Cap: $1.2 Bil
Sector: Health Care | Industry: Health Care Facilities

Pennant (PNTG)


Market Price (2/28/2026): $33.71
Market Cap: $1.2 Bil
Sector: Health Care
Industry: Health Care Facilities

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 30%
Trading close to highs
Dist 52W High is 0.0%
Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 26x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 24x, P/EPrice/Earnings or Price/(Net Income) is 44x
1 Low stock price volatility
Vol 12M is 40%
  Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.0%
2 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Telehealth Platforms, Show more.
  Key risks
PNTG key risks include [1] an inability to attract and retain the key local leadership essential to its decentralized operating model.
0 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 30%
1 Low stock price volatility
Vol 12M is 40%
2 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Telehealth Platforms, Show more.
3 Trading close to highs
Dist 52W High is 0.0%
4 Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 26x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 24x, P/EPrice/Earnings or Price/(Net Income) is 44x
5 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.0%
6 Key risks
PNTG key risks include [1] an inability to attract and retain the key local leadership essential to its decentralized operating model.

Valuation, Metrics & Events

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Pennant (PNTG) stock has gained about 35% since 10/31/2025 because of the following key factors:

1. Exceptional 2025 Financial Performance and Strong 2026 Guidance.

The Pennant Group reported full-year 2025 revenue of $947.7 million, a 36.3% increase over the prior year, and adjusted diluted EPS of $1.18, which exceeded the midpoint of their updated guidance of $1.16. For the fourth quarter of 2025, revenue was $289.3 million, surpassing analyst estimates by 5.1% and marking a 53.2% increase year-over-year. The company further bolstered investor confidence with its 2026 guidance, projecting revenue between $1.13 billion and $1.17 billion (a 22.4% increase at the midpoint) and adjusted EBITDA of $88.5 million to $94.1 million (a 26% increase at the midpoint).

2. Transformative Strategic Acquisitions.

A significant driver of Pennant's growth was its strategic acquisitions, notably the integration of over 50 home health and hospice locations from UnitedHealth and Amedisys in October 2025, which represented the company's largest acquisition to date. These acquisitions were emphasized by management as substantial contributors to revenue growth and instrumental in expanding Pennant's national footprint.

Show more

Stock Movement Drivers

Fundamental Drivers

The 36.3% change in PNTG stock from 10/31/2025 to 2/27/2026 was primarily driven by a 37.2% change in the company's P/E Multiple.
(LTM values as of)103120252272026Change
Stock Price ($)24.7333.7136.3%
Change Contribution By: 
Total Revenues ($ Mil)7998476.1%
Net Income Margin (%)3.4%3.2%-6.1%
P/E Multiple31.843.737.2%
Shares Outstanding (Mil)3535-0.2%
Cumulative Contribution36.3%

LTM = Last Twelve Months as of date shown

Market Drivers

10/31/2025 to 2/27/2026
ReturnCorrelation
PNTG36.3% 
Market (SPY)0.6%6.9%
Sector (XLV)11.1%33.9%

Fundamental Drivers

The 52.1% change in PNTG stock from 7/31/2025 to 2/27/2026 was primarily driven by a 45.4% change in the company's P/E Multiple.
(LTM values as of)73120252272026Change
Stock Price ($)22.1733.7152.1%
Change Contribution By: 
Total Revenues ($ Mil)74884713.2%
Net Income Margin (%)3.4%3.2%-7.3%
P/E Multiple30.143.745.4%
Shares Outstanding (Mil)3435-0.4%
Cumulative Contribution52.1%

LTM = Last Twelve Months as of date shown

Market Drivers

7/31/2025 to 2/27/2026
ReturnCorrelation
PNTG52.1% 
Market (SPY)8.8%13.9%
Sector (XLV)23.4%27.8%

Fundamental Drivers

The 27.4% change in PNTG stock from 1/31/2025 to 2/27/2026 was primarily driven by a 29.9% change in the company's Total Revenues ($ Mil).
(LTM values as of)13120252272026Change
Stock Price ($)26.4733.7127.4%
Change Contribution By: 
Total Revenues ($ Mil)65284729.9%
Net Income Margin (%)3.2%3.2%-2.8%
P/E Multiple37.943.715.3%
Shares Outstanding (Mil)3035-12.5%
Cumulative Contribution27.4%

LTM = Last Twelve Months as of date shown

Market Drivers

1/31/2025 to 2/27/2026
ReturnCorrelation
PNTG27.4% 
Market (SPY)15.0%24.1%
Sector (XLV)10.5%29.2%

Fundamental Drivers

The 160.5% change in PNTG stock from 1/31/2023 to 2/27/2026 was primarily driven by a 1322.2% change in the company's Net Income Margin (%).
(LTM values as of)13120232272026Change
Stock Price ($)12.9433.71160.5%
Change Contribution By: 
Total Revenues ($ Mil)46084784.1%
Net Income Margin (%)0.2%3.2%1322.2%
P/E Multiple372.243.7-88.3%
Shares Outstanding (Mil)2935-15.2%
Cumulative Contribution160.5%

LTM = Last Twelve Months as of date shown

Market Drivers

1/31/2023 to 2/27/2026
ReturnCorrelation
PNTG160.5% 
Market (SPY)75.0%27.4%
Sector (XLV)25.7%26.8%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
PNTG Return-60%-52%27%91%6%8%-47%
Peers Return3%-16%24%1%26%20%65%
S&P 500 Return27%-19%24%23%16%1%84%

Monthly Win Rates [3]
PNTG Win Rate17%50%50%67%67%50% 
Peers Win Rate50%41%55%52%60%60% 
S&P 500 Win Rate75%42%67%75%67%50% 

Max Drawdowns [4]
PNTG Max Drawdown-67%-60%-6%0%-17%-3% 
Peers Max Drawdown-18%-31%-18%-13%-17%-3% 
S&P 500 Max Drawdown-1%-25%-1%-2%-15%-1% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: ENSG, ADUS, BKD, CHE, EHAB.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 2/27/2026 (YTD)

How Low Can It Go

Unique KeyEventPNTGS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-86.3%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven628.1%34.1%
2022 Inflation ShockTime to BreakevenTime to BreakevenNot Fully Recovered days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-69.4%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven226.5%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven147 days148 days

Compare to ENSG, ADUS, BKD, CHE, EHAB

In The Past

Pennant's stock fell -86.3% during the 2022 Inflation Shock from a high on 1/6/2021. A -86.3% loss requires a 628.1% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Pennant (PNTG)

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.

AI Analysis | Feedback

  • It's like **HCA Healthcare**, but focused on skilled nursing and senior living facilities instead of hospitals.
  • The **Marriott** or **Hilton** of skilled nursing and senior living communities.

AI Analysis | Feedback

  • Senior Living Services: Pennant operates senior living communities providing residential care, assisted living, and memory care services to seniors.
  • Home Health Services: The company offers skilled nursing, physical, occupational, and speech therapy, and other medical services in the comfort of patients' homes.
  • Hospice Services: Pennant provides compassionate end-of-life care, pain management, and emotional and spiritual support to terminally ill patients and their families.

AI Analysis | Feedback

Pennant (PNTG)

Pennant (PNTG) primarily serves individuals through its network of senior living communities and skilled nursing facilities. Its major customers can be categorized as follows:

  • Senior Living Residents: These individuals seek a residential environment that provides support for daily living. This category includes residents in independent living, assisted living, and memory care communities who require varying levels of assistance with activities of daily living (ADLs) or specialized care for cognitive impairments.
  • Skilled Nursing Facility Patients: These individuals require post-acute medical care, rehabilitation services, or long-term skilled nursing care. They typically transition to Pennant's facilities after a hospital stay, surgery, or due to chronic health conditions requiring continuous medical supervision and therapeutic services.

AI Analysis | Feedback

null

AI Analysis | Feedback

Brent Guerisoli Chief Executive Officer

Mr. Guerisoli has served as the Chief Executive Officer of The Pennant Group, Inc. since August 1, 2022, and as Chairman of the Board since January 1, 2025. He was previously the President of Pennant from January 2020. Since joining Pennant in 2012, Mr. Guerisoli has directed growth initiatives across several states and contributed significantly to leadership recruiting, development, and training within the organization. He also led a turnaround in the company's senior living sector. Before becoming President of Pennant, he served as President of Cornerstone, a Pennant subsidiary, starting in 2018. Pennant Group was spun off from The Ensign Group (NASDAQ: ENSG) in 2019.

Lynette Walbom Chief Financial Officer

Ms. Walbom was appointed Chief Financial Officer of The Pennant Group, Inc. effective May 22, 2023. Prior to joining Pennant, she was the vice president of financial reporting and tax for Raising Cane's Restaurants, LLC, where her responsibilities included overseeing acquisitions, accounting systems, and equity management. Before her tenure at Raising Cane's, Ms. Walbom held the position of CFO for a family office investment firm. This firm backed several companies across various industries, including financial services, computer services, real estate development, and franchising.

John J. Gochnour President and Chief Operating Officer

Mr. Gochnour serves as the President and Chief Operating Officer of The Pennant Group, Inc. He was previously the Chief Operating Officer.

Kirk Cheney Executive Vice President

Mr. Cheney holds the title of Executive Vice President at The Pennant Group, Inc. He is also listed as the Executive Vice President, General Counsel, and Corporate Secretary.

Jason Steik Chief Clinical Officer

Mr. Steik is the Chief Clinical Officer for The Pennant Group, Inc.

AI Analysis | Feedback

The Pennant Group (PNTG) faces several key risks, primarily stemming from the highly regulated and litigious nature of the healthcare industry, along with challenges in human capital management.
  1. Regulatory and Reimbursement Uncertainty: As a provider of home health, hospice, and senior living services, Pennant Group is heavily reliant on government programs like Medicare and Medicaid for a significant portion of its revenue. Fluctuations in Medicare and Medicaid payment rates, or changes in the rules governing these programs, can directly impact the company's margins and overall financial performance. Compliance with a complex web of federal and state regulations, including those related to fair housing, fire, and safety, may necessitate unanticipated and costly expenditures. Regulatory and reimbursement risks are consistently identified as a primary concern, threatening the company's earnings and operational stability.
  2. Litigation and Professional Liability Claims: The nature of Pennant Group's services, which involve the care of elderly and often vulnerable patients, inherently carries a significant risk of liability. The company is subject to litigation, including professional liability claims alleging personal injury, which could result in substantial legal costs, large settlement amounts, or damage awards. The healthcare industry has seen an increase in the frequency and severity of such litigation, including class action lawsuits for employee-related claims like wrongful discharge or wage and hour disputes.
  3. Ability to Attract and Retain Key Personnel: Pennant Group operates with a decentralized model, emphasizing strong local leadership within its independent operating subsidiaries. The company's success is highly dependent on its ability to attract and retain key personnel, particularly top CEOs and Chief Clinical Officers, who are often sought after by competitors. A failure to secure and retain these crucial individuals could adversely affect the company's business, financial position, and results of operations.

AI Analysis | Feedback

The rise of highly integrated digital health platforms leveraging artificial intelligence, remote patient monitoring, and advanced virtual care capabilities. These platforms are creating alternative, more efficient, and potentially more preferred models for senior care and home health services, directly challenging traditional, labor-intensive facility-based and in-person home health service delivery. This emerging trend can reduce the demand for traditional facility beds and frequent in-person home health visits by enabling effective care delivery with lower reliance on physical infrastructure and traditional staffing ratios, thereby eroding market share and profitability for conventional providers like Pennant.

AI Analysis | Feedback

The Pennant Group (PNTG) primarily operates in three addressable markets within the United States: home health, hospice care, and senior living services.

Home Health Services

The addressable market for home health services in the U.S. was estimated at approximately $162.35 billion in 2024. This market is projected to grow to approximately $381.40 billion by 2033, with a compound annual growth rate (CAGR) of 10.00% from 2025 to 2033. Other estimates suggest the U.S. home healthcare market size was around $194.24 billion in 2024, expected to reach $222.61 billion by 2025, and projected to be worth approximately $644.37 billion by 2034, at a CAGR of 12.74% from 2025 to 2034.

Hospice Care Services

The U.S. hospice market was valued at approximately $29.92 billion in 2024. This market is projected to reach about $39.09 billion by 2030, growing at a CAGR of 4.61% from 2025 to 2030. Another estimate for the U.S. hospice market size in 2024 was $30.25 billion, with a projection to reach around $47.52 billion by 2034 at a CAGR of 4.62% from 2025 to 2034. The market size for Hospices & Palliative Care Centers in the U.S. is estimated at $39.0 billion in 2025.

Senior Living Services

The addressable market for senior living services in the U.S. exhibits a range of estimates. One source estimated the U.S. senior living market size at $907.59 billion in 2024, with an expectation to reach $1.33 trillion by 2033, growing at a CAGR of 4.42% from 2025 to 2033. Another report valued the U.S. senior living market at $923.20 billion in 2023, projecting growth to approximately $1.22 trillion by 2030 at a CAGR of 4.16%. Other estimates place the U.S. senior living market at around $111.20 billion in 2024, with a projection to reach approximately $201.03 billion by 2034 at a CAGR of 6.10% between 2025 and 2034. Pennant's offerings in this segment include residential accommodations, activities, meals, housekeeping, and assistance with daily living for independent seniors or those requiring some support.

AI Analysis | Feedback

Here are 3-5 expected drivers of future revenue growth for Pennant (PNTG) over the next 2-3 years:

  1. Acquisitions and Strategic Expansion: Pennant consistently pursues strategic acquisitions to expand its market presence and operational capabilities. A significant recent example is the acquisition of 54 operations from UnitedHealth Group and Amedisys in October 2025, which is expected to serve as a platform for growth in the Southeastern United States. The company continues to evaluate additional acquisition opportunities.
  2. Organic Growth in Home Health and Hospice Services: The Home Health and Hospice segment is a primary revenue driver, accounting for a substantial portion of Pennant's total revenue. Future growth is anticipated through increased patient admissions and a rising average daily census within these services.
  3. Occupancy Growth and Pricing in Senior Living Services: Revenue growth in the Senior Living segment is expected to be fueled by incremental occupancy gains in its communities and an increase in the average monthly revenue per occupied room.
  4. Demographic Tailwinds: The increasing senior population in the United States acts as a significant demographic tailwind, supporting organic growth and driving higher utilization rates across Pennant's senior care segments.
  5. Operational Efficiencies and Margin Expansion: While primarily impacting profitability, improved operational efficiencies resulting from the scaling of operations and investments in technology are expected to contribute to higher profit margins. This enhanced efficiency and profitability can support sustained revenue growth and provide capital for further expansion.

AI Analysis | Feedback

Share Repurchases

  • On December 13, 2022, The Pennant Group announced a share repurchase program authorized to repurchase common stock, which expired on December 12, 2023.
  • This program was intended to allow opportunistic investment in the company's stock when it was undervalued.
  • As of September 30, 2025, and December 31, 2024, treasury stock at cost remained at $65,000, representing 3 shares.

Share Issuance

  • The Pennant Group has diluted its shareholders, with the share count increasing by 16.6% over a five-year period.
  • The issuance of common stock from the exercise of options resulted in $909,000 for the nine months ended September 30, 2025, and $2,019,000 for the nine months ended September 30, 2024.
  • A Q1 2025 equity offering positively impacted the company's financial performance.

Outbound Investments

  • Pennant has made a total of 14 acquisitions, with significant activity in 2020 (4 acquisitions), 2023 (3 acquisitions), and 2025 (2 acquisitions as of September).
  • On October 1, 2025, Pennant completed the acquisition of 54 home health, hospice, and personal care operations from UnitedHealth Group and Amedisys for $146.5 million, primarily in Tennessee, Alabama, and Georgia.
  • In November 2025, Pennant acquired operations and real property for a 55-bed assisted living community in Lewiston, Idaho (Twin Rivers Senior Living) and completed the purchase of real property for Honey Creek Heights Senior Living in West Allis, Wisconsin, adding 135 beds.

Capital Expenditures

  • Net cash used in investing activities, which includes capital expenditures and acquisitions, was $(74,950) thousand for the nine months ended September 30, 2025, and $(66,287) thousand for the nine months ended September 30, 2024.
  • Capital expenditures reflected in accounts payable and accrued liabilities amounted to $1,076,000 for the nine months ended September 30, 2025, and $1,630,000 for the nine months ended September 30, 2024.
  • The primary focus of capital allocation, including capital expenditures, is to drive organic growth and acquire additional home health, hospice, and senior living operations in existing and new markets.

Better Bets vs. Pennant (PNTG)

Trade Ideas

Select ideas related to PNTG.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ABT_1302026_Insider_Buying_GTE_1Mil_EBITp+DE_V201302026ABTAbbott LaboratoriesInsiderInsider Buys | Low D/EStrong Insider Buying
Companies with strong insider buying in the last 1 month, positive operating income and reasonable debt / market cap
5.0%5.0%-1.0%
VEEV_1302026_Monopoly_xInd_xCD_Getting_Cheaper01302026VEEVVeeva SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple
-13.5%-13.5%-15.7%
BIIB_1162026_Dip_Buyer_FCFYield01162026BIIBBiogenDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
16.0%16.0%0.0%
BMRN_1162026_Dip_Buyer_FCFYield01162026BMRNBioMarin PharmaceuticalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
12.5%12.5%0.0%
DOCS_1162026_Dip_Buyer_High_CFO_Margins_ExInd_DE01162026DOCSDoximityDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-40.9%-40.9%-42.4%

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

PNTGENSGADUSBKDCHEEHABMedian
NamePennant Ensign Addus Ho.Brookdal.Chemed Enhabit  
Mkt Price33.71214.17103.5315.30410.0113.6168.62
Mkt Cap1.212.31.93.65.90.72.8
Rev LTM8475,0581,3473,2212,5311,0481,939
Op Inc LTM43425123643526294
FCF LTM3618096413605877
FCF 3Y Avg22185107-523115279
CFO LTM4856410322942062166
CFO 3Y Avg3242911515536857135

Growth & Margins

PNTGENSGADUSBKDCHEEHABMedian
NamePennant Ensign Addus Ho.Brookdal.Chemed Enhabit  
Rev Chg LTM29.9%18.7%18.8%3.9%6.5%1.0%12.6%
Rev Chg 3Y Avg22.7%18.7%13.3%6.2%5.9%-1.1%9.7%
Rev Chg Q26.8%20.2%25.0%3.7%3.1%3.9%12.1%
QoQ Delta Rev Chg LTM6.1%4.7%5.7%0.9%0.7%1.0%2.8%
Op Mgn LTM5.0%8.4%9.2%2.0%13.9%5.9%7.2%
Op Mgn 3Y Avg5.0%7.9%8.8%1.1%14.5%4.8%6.5%
QoQ Delta Op Mgn LTM-0.4%0.1%0.0%0.0%-0.8%0.6%0.0%
CFO/Rev LTM5.7%11.2%7.7%7.1%16.6%5.9%7.4%
CFO/Rev 3Y Avg4.6%9.8%10.0%4.9%15.4%5.4%7.6%
FCF/Rev LTM4.3%3.6%7.2%1.3%14.2%5.5%4.9%
FCF/Rev 3Y Avg3.2%4.4%9.2%-1.8%13.0%5.0%4.7%

Valuation

PNTGENSGADUSBKDCHEEHABMedian
NamePennant Ensign Addus Ho.Brookdal.Chemed Enhabit  
Mkt Cap1.212.31.93.65.90.72.8
P/S1.42.41.41.12.30.71.4
P/EBIT26.526.614.8-62.915.925.220.5
P/E43.735.921.8-11.821.2-58.021.5
P/CFO24.321.918.115.914.111.117.0
Total Yield2.3%2.9%4.6%-8.4%5.1%-1.7%2.6%
Dividend Yield0.0%0.1%0.0%0.0%0.4%0.0%0.0%
FCF Yield 3Y Avg3.1%2.5%5.7%-4.6%4.2%11.7%3.6%
D/E0.30.20.11.50.00.70.2
Net D/E0.30.10.11.40.00.70.2

Returns

PNTGENSGADUSBKDCHEEHABMedian
NamePennant Ensign Addus Ho.Brookdal.Chemed Enhabit  
1M Rtn22.6%24.7%1.0%16.7%-5.1%31.9%19.7%
3M Rtn21.7%15.5%-13.9%37.5%-6.5%52.2%18.6%
6M Rtn40.4%24.8%-10.1%98.7%-10.2%72.7%32.6%
12M Rtn32.0%61.7%7.0%161.1%-29.7%64.4%46.8%
3Y Rtn124.4%140.8%-4.7%373.7%-20.5%-11.3%59.9%
1M Excs Rtn24.0%26.1%2.4%18.1%-3.7%33.3%21.1%
3M Excs Rtn18.4%12.6%-15.7%34.3%-8.5%52.8%15.5%
6M Excs Rtn31.5%18.3%-16.5%89.0%-15.8%64.0%24.9%
12M Excs Rtn16.7%46.0%-7.3%147.4%-40.0%49.7%31.3%
3Y Excs Rtn98.6%65.7%-76.3%285.7%-91.5%-85.7%-5.3%

Comparison Analyses

null

Financials

Segment Financials

Revenue by Segment
$ Mil20242023202220212020
Home Health and Hospice Services386342310254207
Senior Living Services148131130137132
All Other110   
Total545473440391339


Price Behavior

Price Behavior
Market Price$33.71 
Market Cap ($ Bil)1.2 
First Trading Date10/01/2019 
Distance from 52W High0.0% 
   50 Days200 Days
DMA Price$29.87$26.98
DMA Trendupup
Distance from DMA12.9%24.9%
 3M1YR
Volatility42.6%40.2%
Downside Capture-37.8645.13
Upside Capture89.7965.33
Correlation (SPY)8.1%25.0%
PNTG Betas & Captures as of 1/31/2026

 1M2M3M6M1Y3Y
Beta0.040.290.330.600.530.76
Up Beta2.070.73-0.690.550.520.52
Down Beta-0.50-0.260.170.780.360.61
Up Capture-28%29%98%73%51%113%
Bmk +ve Days11223471142430
Stock +ve Days12213468129399
Down Capture12%73%39%28%80%99%
Bmk -ve Days9192754109321
Stock -ve Days8192656118342

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with PNTG
PNTG32.6%40.1%0.80-
Sector ETF (XLV)9.9%17.4%0.3828.9%
Equity (SPY)16.5%19.4%0.6623.3%
Gold (GLD)81.3%25.7%2.29-3.2%
Commodities (DBC)13.4%16.9%0.582.7%
Real Estate (VNQ)7.3%16.6%0.2521.7%
Bitcoin (BTCUSD)-20.2%44.9%-0.378.9%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with PNTG
PNTG-9.8%52.6%0.00-
Sector ETF (XLV)8.7%14.5%0.4127.2%
Equity (SPY)13.6%17.0%0.6333.7%
Gold (GLD)23.5%17.1%1.124.6%
Commodities (DBC)10.6%19.0%0.447.3%
Real Estate (VNQ)5.1%18.8%0.1832.4%
Bitcoin (BTCUSD)4.5%57.0%0.3014.7%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with PNTG
PNTG8.4%63.6%0.47-
Sector ETF (XLV)11.1%16.5%0.5633.1%
Equity (SPY)15.4%17.9%0.7439.8%
Gold (GLD)15.3%15.6%0.828.5%
Commodities (DBC)8.7%17.6%0.4117.6%
Real Estate (VNQ)6.6%20.7%0.2839.7%
Bitcoin (BTCUSD)66.2%66.8%1.0619.4%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date2132026
Short Interest: Shares Quantity0.9 Mil
Short Interest: % Change Since 13120268.2%
Average Daily Volume0.3 Mil
Days-to-Cover Short Interest3.4 days
Basic Shares Quantity34.6 Mil
Short % of Basic Shares2.7%

Earnings Returns History

Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
11/5/2025-5.6%0.3%14.5%
8/6/20258.4%17.2%9.1%
2/27/2025-10.8%-9.6%-3.6%
11/6/2024-3.4%-1.0%-9.7%
8/6/2024-1.9%7.4%15.8%
2/28/202410.5%12.0%16.3%
11/7/20238.1%11.6%14.1%
8/8/2023-2.1%5.9%0.3%
...
SUMMARY STATS   
# Positive81113
# Negative13108
Median Positive10.6%12.0%14.5%
Median Negative-6.9%-14.0%-14.9%
Max Positive40.7%49.8%41.8%
Max Negative-23.3%-34.9%-49.1%

SEC Filings

Expand for More
Report DateFiling DateFiling
09/30/202511/05/202510-Q
06/30/202508/06/202510-Q
03/31/202505/06/202510-Q
12/31/202402/27/202510-K
09/30/202411/06/202410-Q
06/30/202408/06/202410-Q
03/31/202405/06/202410-Q
12/31/202302/28/202410-K
09/30/202311/07/202310-Q
06/30/202308/08/202310-Q
03/31/202305/04/202310-Q
12/31/202202/23/202310-K
09/30/202211/07/202210-Q
06/30/202208/08/202210-Q
03/31/202205/09/202210-Q
12/31/202102/28/202210-K

Insider Activity

Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Cheney, Kirk SterlingEVP, GC and Corp SecyDirectSell807202523.3488020,539306,221Form
2Guerisoli, BrentChief Executive OfficerDirectSell731202523.343,99593,2311,913,121Form
3Stringfield, Joanne DirectSell523202529.475,000147,350892,204Form
4Stringfield, Joanne DirectSell505202525.6266517,037775,646Form
5Stringfield, Joanne DirectSell203202527.8866518,540809,635Form